An Assessment of a Rapid SARS-CoV-2 Antigen Test in Bangladesh.
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
12 10 2022
12 10 2022
Historique:
received:
23
01
2022
accepted:
21
04
2021
pubmed:
16
8
2022
medline:
19
10
2022
entrez:
15
8
2022
Statut:
epublish
Résumé
Early detection of SARS-CoV-2 infection is crucial to prevent its spread. This study aimed to document test sensitivity/specificity, correlation with cycle threshold value from polymerase chain reaction (PCR), fitness-for-use in different populations and settings, and user perspectives that could inform large-scale implementation. In this study, we evaluated the performance of a rapid antigen detection test, BD Veritor, and compared this (and another rapid test, Standard Q) against reverse transcription PCR (RT-PCR) in terms of sensitivity and specificity in 130 symptomatic and 130 asymptomatic adults. In addition, we evaluated the suitability and ease of use of the BD Veritor test in a subsample of study participants (n = 42) and implementers (n = 5). At 95% confidence interval, the sensitivity of the BD Veritor and Standard Q test were 70% and 63% in symptomatic and 87% and 73% in asymptomatic individuals, respectively, regarding positive SARS-CoV-2 RT-PCR results. Overall, the BD Veritor test was 78% sensitive and 99.5% specific compared with RT-PCR irrespective of the cycle threshold. This warrants large field evaluation as well as use of the rapid antigen test for quick assessment of SARS-CoV-2 for containment of epidemics in the country.
Identifiants
pubmed: 35970285
doi: 10.4269/ajtmh.22-0068
pii: tpmd220068
pmc: PMC9651516
doi:
Substances chimiques
Antigens, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
845-849Références
Lancet Microbe. 2021 May;2(5):e219-e224
pubmed: 33748803
JAMA Netw Open. 2021 May 3;4(5):e2110071
pubmed: 33988707
ACS Infect Dis. 2020 Sep 11;6(9):2513-2523
pubmed: 32786273
Afr J Lab Med. 2020 Sep 30;9(1):1255
pubmed: 33102170
Virol J. 2021 Feb 13;18(1):34
pubmed: 33581714
Phlebology. 2012 Aug;27(5):250-1
pubmed: 22956651
Virol J. 2020 Nov 13;17(1):177
pubmed: 33187528
Int J Gen Med. 2021 Feb 12;14:435-440
pubmed: 33603450
BMC Med. 2021 Apr 14;19(1):94
pubmed: 33849546
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32404480
ACS Nano. 2020 Apr 28;14(4):3822-3835
pubmed: 32223179